United States Docetaxel Market Report 2018

Publisher Name :
Date: 16-May-2018
No. of pages: 97
Inquire Before Buying

In this report, the United States Docetaxel market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Docetaxel in these regions, from 2013 to 2025 (forecast).

United States Docetaxel market competition by top manufacturers/players, with Docetaxel sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Dr. Reddy

- Celon Laboratories

- Fresenius Kabi India

- VHB Life Sciences

- Sanofi

- Sun Pharma

- RPG Life Sciences

- Natco

- Cipla

- Samarth life sciences

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- 40 mg/ml

- 20 mg/ml

- 10 mg/ml

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Breast cancer

- Non-small cell lung cancer

- Prostate cancer

- Gastric adenocarcinoma cancer

- Head and neck cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Docetaxel Market Report 2018

Table of Contents
United States Docetaxel Market Report 2018
1 Docetaxel Overview
1.1 Product Overview and Scope of Docetaxel
1.2 Classification of Docetaxel by Product Category
1.2.1 United States Docetaxel Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Docetaxel Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 40 mg/ml
1.2.4 20 mg/ml
1.2.5 10 mg/ml
1.3 United States Docetaxel Market by Application/End Users
1.3.1 United States Docetaxel Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Breast cancer
1.3.3 Non-small cell lung cancer
1.3.4 Prostate cancer
1.3.5 Gastric adenocarcinoma cancer
1.3.6 Head and neck cancer
1.4 United States Docetaxel Market by Region
1.4.1 United States Docetaxel Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Docetaxel Status and Prospect (2013-2025)
1.4.3 Southwest Docetaxel Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Docetaxel Status and Prospect (2013-2025)
1.4.5 New England Docetaxel Status and Prospect (2013-2025)
1.4.6 The South Docetaxel Status and Prospect (2013-2025)
1.4.7 The Midwest Docetaxel Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Docetaxel (2013-2025)
1.5.1 United States Docetaxel Sales and Growth Rate (2013-2025)
1.5.2 United States Docetaxel Revenue and Growth Rate (2013-2025)
2 United States Docetaxel Market Competition by Players/Suppliers
2.1 United States Docetaxel Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Docetaxel Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Docetaxel Average Price by Players/Suppliers (2013-2018)
2.4 United States Docetaxel Market Competitive Situation and Trends
2.4.1 United States Docetaxel Market Concentration Rate
2.4.2 United States Docetaxel Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Docetaxel Manufacturing Base Distribution, Sales Area, Product Type
3 United States Docetaxel Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Docetaxel Sales and Market Share by Region (2013-2018)
3.2 United States Docetaxel Revenue and Market Share by Region (2013-2018)
3.3 United States Docetaxel Price by Region (2013-2018)
4 United States Docetaxel Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Docetaxel Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Docetaxel Revenue and Market Share by Type (2013-2018)
4.3 United States Docetaxel Price by Type (2013-2018)
4.4 United States Docetaxel Sales Growth Rate by Type (2013-2018)
5 United States Docetaxel Sales (Volume) by Application (2013-2018)
5.1 United States Docetaxel Sales and Market Share by Application (2013-2018)
5.2 United States Docetaxel Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Docetaxel Players/Suppliers Profiles and Sales Data
6.1 Dr. Reddy
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Docetaxel Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Dr. Reddy Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Celon Laboratories
6.2.2 Docetaxel Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Celon Laboratories Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Fresenius Kabi India
6.3.2 Docetaxel Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Fresenius Kabi India Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 VHB Life Sciences
6.4.2 Docetaxel Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 VHB Life Sciences Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Sanofi
6.5.2 Docetaxel Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Sun Pharma
6.6.2 Docetaxel Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sun Pharma Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 RPG Life Sciences
6.7.2 Docetaxel Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 RPG Life Sciences Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Natco
6.8.2 Docetaxel Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Natco Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Cipla
6.9.2 Docetaxel Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Cipla Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Samarth life sciences
6.10.2 Docetaxel Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Samarth life sciences Docetaxel Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
7 Docetaxel Manufacturing Cost Analysis
7.1 Docetaxel Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Docetaxel
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Docetaxel Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Docetaxel Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Docetaxel Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Docetaxel Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Docetaxel Sales Volume Forecast by Type (2018-2025)
11.3 United States Docetaxel Sales Volume Forecast by Application (2018-2025)
11.4 United States Docetaxel Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Docetaxel
Figure United States Docetaxel Market Size (K Units) by Type (2013-2025)
Figure United States Docetaxel Sales Volume Market Share by Type (Product Category) in 2017
Figure 40 mg/ml Product Picture
Figure 20 mg/ml Product Picture
Figure 10 mg/ml Product Picture
Figure United States Docetaxel Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Docetaxel by Application in 2017
Figure Breast cancer Examples
Table Key Downstream Customer in Breast cancer
Figure Non-small cell lung cancer Examples
Table Key Downstream Customer in Non-small cell lung cancer
Figure Prostate cancer Examples
Table Key Downstream Customer in Prostate cancer
Figure Gastric adenocarcinoma cancer Examples
Table Key Downstream Customer in Gastric adenocarcinoma cancer
Figure Head and neck cancer Examples
Table Key Downstream Customer in Head and neck cancer
Figure United States Docetaxel Market Size (Million USD) by Region (2013-2025)
Figure The West Docetaxel Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Docetaxel Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Docetaxel Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Docetaxel Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Docetaxel Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Docetaxel Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Docetaxel Sales (K Units) and Growth Rate (2013-2025)
Figure United States Docetaxel Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Docetaxel Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Docetaxel Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Docetaxel Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Docetaxel Sales Share by Players/Suppliers
Figure 2017 United States Docetaxel Sales Share by Players/Suppliers
Figure United States Docetaxel Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Docetaxel Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Docetaxel Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Docetaxel Revenue Share by Players/Suppliers
Figure 2017 United States Docetaxel Revenue Share by Players/Suppliers
Table United States Market Docetaxel Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Docetaxel Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Docetaxel Market Share of Top 3 Players/Suppliers
Figure United States Docetaxel Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Docetaxel Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Docetaxel Product Category
Table United States Docetaxel Sales (K Units) by Region (2013-2018)
Table United States Docetaxel Sales Share by Region (2013-2018)
Figure United States Docetaxel Sales Share by Region (2013-2018)
Figure United States Docetaxel Sales Market Share by Region in 2017
Table United States Docetaxel Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Docetaxel Revenue Share by Region (2013-2018)
Figure United States Docetaxel Revenue Market Share by Region (2013-2018)
Figure United States Docetaxel Revenue Market Share by Region in 2017
Table United States Docetaxel Price (USD/Unit) by Region (2013-2018)
Table United States Docetaxel Sales (K Units) by Type (2013-2018)
Table United States Docetaxel Sales Share by Type (2013-2018)
Figure United States Docetaxel Sales Share by Type (2013-2018)
Figure United States Docetaxel Sales Market Share by Type in 2017
Table United States Docetaxel Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Docetaxel Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Docetaxel by Type (2013-2018)
Figure Revenue Market Share of Docetaxel by Type in 2017
Table United States Docetaxel Price (USD/Unit) by Types (2013-2018)
Figure United States Docetaxel Sales Growth Rate by Type (2013-2018)
Table United States Docetaxel Sales (K Units) by Application (2013-2018)
Table United States Docetaxel Sales Market Share by Application (2013-2018)
Figure United States Docetaxel Sales Market Share by Application (2013-2018)
Figure United States Docetaxel Sales Market Share by Application in 2017
Table United States Docetaxel Sales Growth Rate by Application (2013-2018)
Figure United States Docetaxel Sales Growth Rate by Application (2013-2018)
Table Dr. Reddy Basic Information List
Table Dr. Reddy Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dr. Reddy Docetaxel Sales Growth Rate (2013-2018)
Figure Dr. Reddy Docetaxel Sales Market Share in United States (2013-2018)
Figure Dr. Reddy Docetaxel Revenue Market Share in United States (2013-2018)
Table Celon Laboratories Basic Information List
Table Celon Laboratories Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celon Laboratories Docetaxel Sales Growth Rate (2013-2018)
Figure Celon Laboratories Docetaxel Sales Market Share in United States (2013-2018)
Figure Celon Laboratories Docetaxel Revenue Market Share in United States (2013-2018)
Table Fresenius Kabi India Basic Information List
Table Fresenius Kabi India Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Fresenius Kabi India Docetaxel Sales Growth Rate (2013-2018)
Figure Fresenius Kabi India Docetaxel Sales Market Share in United States (2013-2018)
Figure Fresenius Kabi India Docetaxel Revenue Market Share in United States (2013-2018)
Table VHB Life Sciences Basic Information List
Table VHB Life Sciences Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure VHB Life Sciences Docetaxel Sales Growth Rate (2013-2018)
Figure VHB Life Sciences Docetaxel Sales Market Share in United States (2013-2018)
Figure VHB Life Sciences Docetaxel Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Docetaxel Sales Growth Rate (2013-2018)
Figure Sanofi Docetaxel Sales Market Share in United States (2013-2018)
Figure Sanofi Docetaxel Revenue Market Share in United States (2013-2018)
Table Sun Pharma Basic Information List
Table Sun Pharma Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sun Pharma Docetaxel Sales Growth Rate (2013-2018)
Figure Sun Pharma Docetaxel Sales Market Share in United States (2013-2018)
Figure Sun Pharma Docetaxel Revenue Market Share in United States (2013-2018)
Table RPG Life Sciences Basic Information List
Table RPG Life Sciences Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure RPG Life Sciences Docetaxel Sales Growth Rate (2013-2018)
Figure RPG Life Sciences Docetaxel Sales Market Share in United States (2013-2018)
Figure RPG Life Sciences Docetaxel Revenue Market Share in United States (2013-2018)
Table Natco Basic Information List
Table Natco Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Natco Docetaxel Sales Growth Rate (2013-2018)
Figure Natco Docetaxel Sales Market Share in United States (2013-2018)
Figure Natco Docetaxel Revenue Market Share in United States (2013-2018)
Table Cipla Basic Information List
Table Cipla Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cipla Docetaxel Sales Growth Rate (2013-2018)
Figure Cipla Docetaxel Sales Market Share in United States (2013-2018)
Figure Cipla Docetaxel Revenue Market Share in United States (2013-2018)
Table Samarth life sciences Basic Information List
Table Samarth life sciences Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Samarth life sciences Docetaxel Sales Growth Rate (2013-2018)
Figure Samarth life sciences Docetaxel Sales Market Share in United States (2013-2018)
Figure Samarth life sciences Docetaxel Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Docetaxel
Figure Manufacturing Process Analysis of Docetaxel
Figure Docetaxel Industrial Chain Analysis
Table Raw Materials Sources of Docetaxel Major Players/Suppliers in 2017
Table Major Buyers of Docetaxel
Table Distributors/Traders List
Figure United States Docetaxel Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Docetaxel Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Docetaxel Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Docetaxel Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Docetaxel Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Docetaxel Sales Volume (K Units) Forecast by Type in 2025
Table United States Docetaxel Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Docetaxel Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Docetaxel Sales Volume (K Units) Forecast by Application in 2025
Table United States Docetaxel Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Docetaxel Sales Volume Share Forecast by Region (2018-2025)
Figure United States Docetaxel Sales Volume Share Forecast by Region (2018-2025)
Figure United States Docetaxel Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Erlotinib Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erlotinib Hydrochloride in these regions. This research report categorizes the global Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2018        Price: US 2000 Onwards        Pages: 120
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - ......
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global and India Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 99
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer ......
  • Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Trea......
  • Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 122
    Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells ......
  • 2018-2023 Global Cancer Treatment Drugs Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 179
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Treatment Drugs market for 2018-2023. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted th......
  • Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 137
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs